Loading...
•
Jun 30, 2022
Treace Q2 2022 Earnings Report
Reported a 45% increase in revenue compared to the same period last year.
Key Takeaways
Treace Medical Concepts reported a strong second quarter with a 45% increase in revenue, driven by an expanded surgeon customer base and increased adoption of newer technologies. The company is raising its full-year 2022 revenue guidance to $130 million to $134 million.
Revenue of $30.0 million, a 45% increase over the same period last year.
Gross margin of 81.1%, an increase of 20 basis points from the same period last year.
Direct sales channel contributed 68% of sales, an increase from 51% during the second quarter 2021.
Cash and cash equivalents of $101.5 million provide sufficient cash to fund initiatives into profitability.
Forward Guidance
Treace is raising its full-year 2022 revenue guidance to $130 million to $134 million, which represents approximately 38% to 42% growth over the Company’s 2021 revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...